AN INHALABLE FORMULATION OF FLUTICASONE PROPIONATE AND ALBUTEROL SULFATE
This invention relates to a fixed-dose dry powder inhalation formulation comprising fluticasone propionate and albuterol sulfate, together with an α-lactose monohydrate carrier. In the formulation, the albuterol sulfate stabilises fluticasone propionate.
Saved in:
| Main Authors | , , , , |
|---|---|
| Format | Patent |
| Language | English French German |
| Published |
21.06.2023
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | This invention relates to a fixed-dose dry powder inhalation formulation comprising fluticasone propionate and albuterol sulfate, together with an α-lactose monohydrate carrier. In the formulation, the albuterol sulfate stabilises fluticasone propionate. |
|---|---|
| AbstractList | This invention relates to a fixed-dose dry powder inhalation formulation comprising fluticasone propionate and albuterol sulfate, together with an α-lactose monohydrate carrier. In the formulation, the albuterol sulfate stabilises fluticasone propionate. |
| Author | SHAH, Hardik Kirtikumar EDLIN, Chris David O'NEILL, Brian Paul BLAIR, Julian Alexander MCKEON, Shane Michael |
| Author_xml | – fullname: O'NEILL, Brian Paul – fullname: BLAIR, Julian Alexander – fullname: EDLIN, Chris David – fullname: SHAH, Hardik Kirtikumar – fullname: MCKEON, Shane Michael |
| BookMark | eNqNyk0KwjAQQOEsdOHfHeYCgkEtuJzWhATGTGiTdSkyriQt1PtjFx7A1YOPt1WrMhbZKIcBfHBIWJMBy-0jEybPAdiCpZx8gx0HA7HluDAmAxjugFTnZFom6DLZRfdq_Rresxx-3SmwJjXuKNPYyzwNTyny6U286FulT1fU5z-WL9S5Lkw |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | EINE INHALIERBARE FORMULIERUNG VON FLUTICASONPROPIONAT UND ALBUTEROLSULFAT FORMULATION INHALABLE DE PROPIONATE DE FLUTICASONE ET DE SULFATE D'ALBUTÉROL |
| ExternalDocumentID | EP4196105A1 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_EP4196105A13 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 12:58:13 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English French German |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_EP4196105A13 |
| Notes | Application Number: EP20210765851 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230621&DB=EPODOC&CC=EP&NR=4196105A1 |
| ParticipantIDs | epo_espacenet_EP4196105A1 |
| PublicationCentury | 2000 |
| PublicationDate | 20230621 |
| PublicationDateYYYYMMDD | 2023-06-21 |
| PublicationDate_xml | – month: 06 year: 2023 text: 20230621 day: 21 |
| PublicationDecade | 2020 |
| PublicationYear | 2023 |
| RelatedCompanies | Norton (Waterford) Limited |
| RelatedCompanies_xml | – name: Norton (Waterford) Limited |
| Score | 3.470011 |
| Snippet | This invention relates to a fixed-dose dry powder inhalation formulation comprising fluticasone propionate and albuterol sulfate, together with an α-lactose... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | AN INHALABLE FORMULATION OF FLUTICASONE PROPIONATE AND ALBUTEROL SULFATE |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230621&DB=EPODOC&locale=&CC=EP&NR=4196105A1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3PT8IwFG4IGvWmqBF_pQez2yIbZciBmG7rMkzZFtgMN7J2PXAZRGb8931tAL3o7aVNmvalr_3e63tfEXoa9FQ5HCppu1KObFJJxxb9PoG9DM7K0KvKngnoTxMvLsjbYrBoodW-FsbwhH4ZckSwKAn23pjzevMTxApNbuX2Waygaf0a5ePQ2nnHGk-7jhX6Y5alYRpYQQCSlczGBHYaQAkKjtKRRtGaZp-9-7ooZfP7RonO0XEGg9XNBWqpuoNOg_3Hax10Mt29d4O4M73tJYppgidJTDn1OcPgu00LbuJLOI1wxIt8EtB5mjCczdJME9zmDNMkxJT7BUDWlON5wSNovUI4YnkQ2zCl5WH5S5YdJt-_Ru16XasbhF_kQCj9_bkaeaSqpCBElJVQVamc0vPcLur-OcztP3136EzrUWdDuc49ajcfn-oB7t1GPBqNfQO5mIGB |
| link.rule.ids | 230,309,786,891,25594,76906 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV07T8MwED5VBVE2KCDK0wPKFtGkbkKHCuWpFJyH2gR1qxLHQ5e0aoP4-5yjtrDAdrIlyz757O_Od58BnoZ9kZum4KrO-UilJdfUYjCguJfRWTGNMu83Af0wMoKMvs2H8xYs97UwDU_oV0OOiBbF0d7r5rxe_wSx3Ca3cvtcLLFp9eqnY1fZeccST-ua4tpjL4nd2FEcByUlmo4p7jSEEhY6SkemJOeVyOnDlkUp6983in8GxwkOVtXn0BJVFzrO_uO1LpyEu_duFHemt72AwIrIJAosZtnMI-i7hRlr4ksk9onPsnTiWLM48kgyjRNJcJt6xIpcYjE7Q8gaMzLLmI-tl0B8L3UCFae0OCx_4SWHyQ-uoF2tKnEN5IUPCyG_Pxcjg5YlLygt8rIQZS603DD0HvT-HObmn75H6ARpyBZsEr3fwqnUqcyM0rU7aNebT3GPd3BdPDTa-wbwqYRu |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=AN+INHALABLE+FORMULATION+OF+FLUTICASONE+PROPIONATE+AND+ALBUTEROL+SULFATE&rft.inventor=O%27NEILL%2C+Brian+Paul&rft.inventor=BLAIR%2C+Julian+Alexander&rft.inventor=EDLIN%2C+Chris+David&rft.inventor=SHAH%2C+Hardik+Kirtikumar&rft.inventor=MCKEON%2C+Shane+Michael&rft.date=2023-06-21&rft.externalDBID=A1&rft.externalDocID=EP4196105A1 |